Case Type: Mergers & Acquisitions

Agile Therapeutics, Inc. (OTCQB: AGRX), relating to its proposed merger with Insud Pharma, S.L. Under the terms of the agreement, Agile Therapeutics shareholders will receive $1.52 per share of Agile stock they own in cash.

Marathon Oil Corp (NYSE: MRO), relating to its proposed merger with ConocoPhillips. Under the terms of the agreement, Marathon Oil shareholders will receive 0.255 shares of ConocoPhillips common stock for each share of Marathon Oil Corp. stock they held.

Alimera Sciences, Inc. (Nasdaq: ALIM), relating to its proposed merger with ANI Pharmaceuticals, Inc. Under the terms of the agreement, Alimera Sciences shareholders will receive $5.50 per share, and one contingent value right which shall represent the right to receive up to $0.50 per share contingent on reaching certain net revenue targets in 2026 and 2027.

AdTheorent Holding Company, Inc. (Nasdaq: ADTH), relating to its proposed merger with Cadent, LLC. Under the terms of the agreement, AdTheorent Holding Company shareholders will receive $3.21 in cash for each share they own.

The Aaron’s Company, Inc. (NYSE: AAN), relating to its proposed merger with IQVentures Holdings, LLC. Under the terms of the agreement, The Aaron’s Company shareholders will receive $10.10 in cash for each share they own.

PowerSchool Holdings, Inc. (NYSE: PWSC), relating to its proposed merger with Bain Capital Private Equity, LP. Under the terms of the agreement, PowerSchool Holdings, Inc. will receive $22.80 in cash for each share they own.

Diamond Offshore Drilling, Inc. (NYSE: DO), relating to its proposed merger with Noble Corp plc. Under the terms of the agreement, each share of Diamond Offshore Drilling stock will be converted into the right to receive $5.65 in cash and 0.2316 shares of Noble stock.

ICC Holdings, Inc. (NASDAQ: ICCH), relating to its proposed merger with Mutual Capital Holdings, Inc., and Mutual Capital Merger Sub, Inc. Under the terms of the agreement, ICC Holdings shareholders will receive $23.50 in cash for each share they own.

Southern California Bancorp (NASDAQ: BCAL), relating to its proposed merger with California BanCorp. Under the terms of the agreement, Southern California Bancorp shareholders will own approximately 57.1% of outstanding shares of the combined company.

Asensus Surgical, Inc. (NYSE: ASXC), relating to its proposed merger with KARL STORZ Endoscopy-America, Inc., a wholly owned direct subsidiary of KARL STORZ SE & Co. KG. Under the terms of the agreement, KARL STORZ Endoscopy-America, Inc., and Karl Storz California Inc. will acquire each outstanding share of Asensus Surgical stock for $0.35 in cash, without … Read more